Associated Papers
Finding driver mutations in cancer: Elucidating the role of background mutational processes.
Brown AL et al.
Plos Computational Biology, 2019
31034466 (PubMed )
Supplement: pcbi.1006981.s010.xlsx › final_benchmark
HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.
Wang T et al.
Cancer Science, 2017
EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation.
Trowe T et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2008
Select a paper to view details